Linseed / Flaxseed

Metadata

• Common Names: Linseed, Flaxseed, Common Flax (English); Leinsamen (German)
• Botanical Name: Linum usitatissimum L.
• Plant Family: Linaceae
• Part Used: Ripe, dried seed (Lini semen)
• Evidence Quality Rating: Moderate (well-established use per EMA for constipation; additional indications have varying evidence levels)

Approved Indications

Commission E

• Habitual constipation
• Intestinal damage due to laxative abuse (rehabilitation)
• Irritable bowel syndrome (irritable colon)
• Diverticulitis
• Gastritis, enteritis (mucilage as demulcent/protective agent)
• As poultice: Local inflammation (external)

ESCOP

• Habitual constipation (chronic constipation)
• Conditions requiring easy bowel movements with soft stools
• Gastritis and enteritis (demulcent/protective)
• Supportive treatment of dyslipidemia
• Supportive treatment of hypertension

EMA/HMPC

• Well-established use: Habitual constipation; conditions where easy defecation with soft stools is desired
• Traditional use: Symptomatic relief of minor gastrointestinal discomfort (as demulcent)
• The EMA grants “well-established use” status for constipation based on bibliographic scientific evidence covering at least 10 years of established use in the EU

Agreement/Disagreement Between Bodies

• All three bodies agree on habitual constipation as the primary indication
• Commission E uniquely includes diverticulitis and intestinal rehabilitation after laxative abuse
• Commission E and ESCOP agree on gastritis/enteritis (demulcent use); EMA includes this as traditional use
• ESCOP adds lipid-lowering and antihypertensive supportive indications
• All agree on well-established status for constipation

Conditions Treated

• Habitual / Chronic constipation
• Irritable bowel syndrome
• Gastritis / Enteritis (demulcent/mucosal protection)
• Diverticular disease
• Intestinal rehabilitation after laxative abuse
• Mild hyperlipidemia (adjunct)
• Hypertension (adjunct, via dietary omega-3 ALA content)
• Local skin inflammation (poultice, external)

Mechanism of Action

Bulk-Forming / Laxative Mechanism

• Mucilage content (3-9% of seed, concentrated in seed coat): Swells on contact with water to form a thick gel (up to 8-14 times its volume)
• Intestinal distension: The swollen mucilage mass stimulates peristaltic reflex by stretching the intestinal wall
• Stool softening: Gel retains water within the fecal mass, producing softer stools
• Lubrication: Oil content (30-40%) provides additional lubrication of intestinal contents

Demulcent / Mucosal Protective Mechanism

• Mucilage forms a protective coating over inflamed gastrointestinal mucosa
• Reduces direct contact between irritants and the mucosal surface
• Useful in gastritis and enteritis

Additional Bioactive Components

• Alpha-linolenic acid (ALA) (50-60% of oil fatty acids): Omega-3 fatty acid; anti-inflammatory; substrate for EPA/DHA synthesis (limited conversion rate)
• Lignans (secoisolariciresinol diglucoside/SDG): Phytoestrogen; antioxidant; may contribute to lipid-lowering and cardiovascular protective effects
• Dietary fiber: Both soluble (mucilage) and insoluble fiber contribute to bowel regulation
• Cyanogenic glycosides (linustatin, neolinustatin, linamarin): Present in seed; release small amounts of hydrogen cyanide when crushed and hydrated (see Safety section)

Clinical Evidence Summary

Constipation

• Well-established efficacy: EMA “well-established use” designation based on extensive clinical documentation
• Over 20 clinical studies referenced in Commission E and ESCOP assessments
• Comparable to psyllium for chronic constipation in some studies, though head-to-head data is limited
• Linseed appears to increase stool frequency and improve stool consistency

IBS

• Commission E includes IBS as an indication
• Limited dedicated RCT data for linseed monotherapy in IBS specifically
• Mechanism of action (stool normalization, mucilage protection) is pharmacologically plausible for IBS

Lipid Lowering

• Multiple clinical trials show modest reductions in total cholesterol and LDL
• Flaxseed at doses of 30-50 g/day has shown 5-15% reductions in LDL cholesterol in some studies
• The ALA and lignan content contribute to the cardiovascular effects
• Less robust evidence than psyllium for cholesterol lowering

Gastritis / Mucous Membrane Protection

• Traditional use well-documented; pharmacological rationale (mucilage demulcent effect) is clear
• Limited controlled clinical trial data specifically for gastritis [NEEDS-RESEARCH]

Blood Pressure

• Some clinical trials show modest blood pressure reductions with flaxseed supplementation (primarily attributed to ALA content)
• Not a primary indication but recognized as supportive by ESCOP

European vs US/Anglophone Consensus

• In Germany, linseed is a standard pharmacy product for constipation; “Leinsamen” preparations are widely available
• The Commission E indications (constipation, IBS, gastritis, diverticulitis) reflect a broader therapeutic view than US practice
• In the US, flaxseed is primarily promoted as a dietary supplement for omega-3 fatty acids and fiber, not specifically as a constipation remedy
• US emphasis is on flaxseed oil and lignans for cardiovascular health, while European emphasis is on whole/crushed seed for GI function
• The demulcent (gastritis/enteritis) use is distinctly European and has no parallel in US clinical practice
• European preparation method (whole or freshly crushed seeds taken with ample water) differs from US consumption patterns (ground flaxseed added to food)

Safety Profile

Contraindications

• Esophageal stricture or difficulty swallowing: Risk of obstruction
• Bowel obstruction or fecal impaction
• Acute intestinal inflammation
• Hormone-sensitive conditions: Phytoestrogens (lignans) may have weak estrogenic activity; caution in breast cancer, ovarian cancer, uterine cancer, endometriosis, uterine fibroids
• Narrowing of the esophagus (esophageal stricture)

Cyanogenic Glycoside Safety

• Flaxseeds contain cyanogenic glycosides (linustatin: 213-352 mg/100g; neolinustatin: 91-203 mg/100g; linamarin: <32 mg/100g)
• When crushed and hydrated, these release small amounts of hydrogen cyanide (HCN)
• Risk assessment: At normal consumption (up to 30 g ground flaxseed per meal), risk to adults and adolescents from age 13 can be largely ruled out
• The body can effectively detoxify small amounts of cyanide via rhodanese enzyme (converts HCN to thiocyanate)
• Heating destroys cyanogenic glycosides
• European authorities (AGES Austria, EFSA) have assessed the risk as minimal at recommended doses
• Concern is greater for children, who should consume proportionally less

Drug Interactions

• Mechanical absorption interference: Similar to psyllium, linseed mucilage can delay or reduce absorption of other medications; take medications at least 1 hour before or 2 hours after linseed
• Phytoestrogen interactions: May interact with estrogen-containing medications or tamoxifen (pharmacodynamic synergism)
• Anticoagulants: ALA may have mild antiplatelet effects; theoretical additive bleeding risk with warfarin/anticoagulants
• Antidiabetic medications: May modestly affect blood glucose levels
• No known severe drug interactions

Side Effects

• Bloating and flatulence (common, especially initially)
• Abdominal discomfort
• Diarrhea (if excessive intake or insufficient fluid)
• Intestinal obstruction: Rare; can occur if taken with insufficient water or in patients with strictures
• Allergic reactions: Very rare (flax allergy documented in occupational settings)

Pregnancy/Lactation

• Pregnancy: Generally advised to avoid flaxseed during pregnancy due to phytoestrogenic content (lignan component)
• Some sources consider moderate amounts of whole flaxseed safe, but guidance is conflicting
• Breastfeeding: Advised to avoid or use with caution due to phytoestrogen content
• This is more conservative than the guidance for psyllium

Clinical Dosage

Forms and Ranges

• Whole seeds: 10-15 g (1-2 tablespoons), 2-3 times daily (total 20-45 g/day) with at least 150 mL of water per dose
• Crushed/ground seeds: Same weight range; crushed seeds release more mucilage and oil but also more cyanogenic glycosides
• Pre-soaked seeds: Soak in water for 20-30 minutes before consumption to allow mucilage to swell
• For constipation: Start with 10 g daily and increase gradually to avoid bloating
• For gastritis (demulcent): Prepare mucilage by soaking 5-10 g whole seeds in 200 mL water; strain and drink the mucilaginous liquid
• Duration: Can be used long-term for constipation (unlike stimulant laxatives)
• Critical: Always take with ample water (at least 150 mL per dose)

Key Standardized Products

• Lini semen per European Pharmacopoeia: Minimum swelling index of 4 (whole seed) or 4.5 (crushed seed)
• Leinsamen products widely available in German pharmacies
• Brown and golden (yellow) flaxseed varieties are both acceptable; no significant difference in therapeutic efficacy
• Flaxseed oil (for omega-3 supplementation) is a separate product that does not provide the mucilage/fiber laxative effect

Sources

• EMA/HMPC Herbal Monograph on Linum usitatissimum L., semen
• EMA/HMPC Assessment Report on Linum usitatissimum L., semen
• EMA/HMPC Addendum to Assessment Report on Linum usitatissimum L., semen
• Commission E Monograph: Lini semen
• ESCOP Monograph: Lini semen
• AGES (Austrian Agency for Health and Food Safety): Cyanogenic glycosides in flaxseed
• Arzneipflanzenlexikon: Linseed (arzneipflanzenlexikon.info)
• Kajla P, et al. Flaxseed — a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871
• Kristensen M, et al. Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion. Nutr Metab. 2012;9:8
• Parikh M, et al. Flaxseed: its bioactive components and their cardiovascular benefits. Am J Physiol Heart Circ Physiol. 2018;314(2):H146-H159

Connections

• Compare with Psyllium as fellow bulk-forming laxatives (psyllium has stronger clinical evidence base)
• Compare with Senna for constipation — different mechanisms (bulk-forming vs stimulant)
• The cyanogenic glycoside safety issue parallels the Fennel estragole and Wormwood thujone safety concerns
• The phytoestrogen content connects to broader discussions about botanical hormonal activity
• The demulcent/mucosal protective use links to German Chamomile anti-inflammatory GI applications